Our Hospitals

Business

GPT Healthcare Limited (“the Company”) is engaged in the Healthcare Services i.e running of hospitals and providing medical services. We operate a chain of mid-sized full service hospitals under the brand name of “ILS Hospitals” and provide integrated healthcare services, with a focus on secondary and tertiary care. As of March 31, 2024, we operate four multispecialty hospitals in Dum Dum, Salt Lake and Howrah in West Bengal and Agartala in Tripura with a total capacity of 561 beds.

Postal Ballot

Particulars Download
Postal Ballot Notice
News paper Notice for Postal Ballot and E-voting
Scrutinizer Report
Postal Ballot Result

Shareholding Pattern

Financial Year Q 1 Q 2 Q 3 Q 4
2023 - 2024 NA NA NA

Share Capital

Authorised Share Capital Rs. 125,00,00,000
Divided into 12,50,00,000 Equity Shares of Rs. 10/- Each.
Issued, Paid-Up & Subscribed Capital Rs. 82,05,48,230
Divided into 8,20,54,823 Equity Shares of Rs. 10/- Each.

Earnings Call

Quarter Earnings Presentation Call Invite Earnings Call Transcript
Q4 : 2023-24
Investor Presentations

GHL-Intimation of Earnings Calls 14.05.2024

GHL-Call Transcript 22.05.2024


GHL-Audio Call Recording Q4.mp3

Q3 : 2023-24
Investor Presentations

GHL-Intimation of Earnings Calls 18.03.2024

GHL-Call Transcript 23.03.2024


GHL-Audio Call Recording Q3.mp3

Q2: 2023-24 NA NA NA
Q1: 2023-24 NA NA NA

Dividend

Details of Dividend declared and the respective due dates for transfer of theunclaimed/unpaid dividend to IEPF as on 31.03.2024:

Dividend for the Financial Year Date of declaration of Dividend Type of Dividend Amount of Dividend declared Rate of dividend (%) Due date of Transfer to IEPF Remarks
2023-24 05.01.2024 Interim Dividend 7,99,04,286 10% (Rs. 1.00 per share) 10.01.2031 No Unpaid Dividend
19.03.2024 Interim Dividend 8,20,54,823 10% (Rs. 1.00 per share) 24.04.2031 -

Unpaid Dividend

There are no unclaimed and unpaid amount pending with company till 31.03.2024.

Corporate Policies

Policy Document Download
GHL-Board Performance Appraisal Policy
GHL-Code of Conduct for Board and Senior Mangers
GHL-Code of Conduct for Prevention of Insider Trading
GHL-Code of Corporate Disclosure for PIT
GHL-Criteria for making payment to Non Executive Directors
GHL-CSR Policy
GHL-Diversity Policy
GHL-Dividend Policy
GHL-Familiarisation Programme for IDs
GHL-Materiality Policy for Disclosure in Offer Documents
GHL-Materiality Subsidiary Policy
GHL-Nomination and Remuneration Policy
GHL-Policy for Determining Materiality for Disclosure
GHL-Policy for Document Retention and Archival
GHL-Policy on Succession Planning
GHL-Related Party Transactions Policy
GHL-Risk Management Policy
GHL-Sexual Harassment Policy
GHL-Terms of Appointment of Independent Director
GHL-Vigil Mechanism Policy

Compliances

Compliance under Reg.32 of Listing Regulations

Compliances Document Download
Statement Of Deviation For The Quarter Ended March 31, 2024

Compliance under Reg. 40(9) of Listing Regulations

Compliances Document Download
Certificate pursuant to Regulation 40(9) & (10) of the SEBI (LODR), Regulations, 2015 for the Q.E March 31, 2024

Compliance under Reg. 40(9) of Listing Regulations

Compliances Document Download
Certificate pursuant to Regulation 40(9) & (10) of the SEBI (LODR), Regulations, 2015 for the Q.E March 31, 2024

Reconciliation of Share Capital Audit

Compliances Document Download
Reconciliation of Share Capital Audit

Compliance under Reg. 13(3) of Listing Regulations

Compliances Document Download
Investor Compliant for the Q.E 31.03.2024 XBRL

Compliance under Reg.7(3) of Listing Regulations

Compliances Document Download
Compliance Certificate under reg 7(3) of the SEBI (LODR) Regulations, 2015 for the year ended March 31, 2024.

Notices

Type Subject Financial Year Details Download
Board Meeting Notice Intimation of Board Meeting to be held on May 21, 2024 2024-25 Approval of FR for the Q4 and Year ended March 31, 2024
GHL-Intimation of Board Meeting
AGM, Book Closure Record date Record Date Notice for Dividend 2023-24 Intimation regarding the 35th AGM, Dividend & Book Closure and Record date
GHL-AGM, Record Date and Book Closure
Board Meeting Notice Intimation of Board Meeting to be held on March 19, 2024. 2023-24 Approval of UFR for the Q3 9M ended December 31, 2023
GHL-Notice of Board Meetings
Record date Record Date Notice for Dividend 2023-24 Second Interim Dividend
GHL-Revised Record Date Notice

Disclosure Information

Date Document Download
29.05.2024 Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
29.05.2024 Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
27.05.2024 Update on Conference Call held on May 22, 2024– Call Transcript
23.05.2024 Newspaper Publication of Q4FY24 Financial Results
23.05.2024 Filing of Secretarial Compliance Report for the year ended March 31, 2024
22.05.2024 Audio Recording of Q4 Earnings call held today i.e May 22, 2024
21.05.2024 Change in Directorate
21.05.2024 Statement Of Deviation For The Quarter Ended March 31, 2024
21.05.2024 Outcome of Board Meeting held on May 21, 2024
21.05.2024 Submission of Results for the Q4 and Year ended March 31, 2024
21.05.2024 Press Release for the Q4 and Year ended March 31, 2024
21.05.2024 Submission of Investors Presentation Q4 FY2024
21.05.2024 Details of 35th Annual General Meeting, Book Closure Date and Record Date for Dividend
14.05.2024 Intimation of Earnings Call to discuss the financial performance of the Company for the 4th quarter and year ended March 31, 2024.
14.05.2024 Intimation of Board Meeting pursuant to Regulations 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on May 21, 2024
14.05.2024 Intimation of Board Meeting pursuant to Regulations 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on May 21, 2024
10.05.2024 Disclosure of Postal Ballot Results along with Scrutinizer Report
09.05.2024 Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
26.04.2024 Intimation regarding change of Corporate Identification Number ("CIN") of GPT Healthcare Limited ("The Company")
25.04.2024 Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
25.04.2024 Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Execution of Lease Agreement
24.04.2024 Compliance Certificate under reg 7(3) of the SEBI (LODR) Regulations, 2015 for the year ended March 31, 2024
24.04.2024 Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
20.04.2024 Resignation of Dr. Bharbi Chattopadhayay, SMP
16.04.2024 Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E March 31, 2024
16.04.2024 Certificate pursuant to Regulation 40(9) & (10) of the SEBI (LODR), Regulations, 2015 for the Q.E March 31, 2024
16.04.2024 Fund raising by issuance of debt securities by Large Entities
16.04.2024 Reconciliation of Share Capital Audit Report for the quarter ended March 31, 2024.
12.04.2024 Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
09.04.2024 Newspaper Publication of Postal Ballot Notice
08.04.2024 Notice of Postal Ballot
28.03.2024 Closure of Trading Window
23.03.2024 Transcript of Conference Call held on Thursday, March 21, 2024.
21.03.2024 Revision of Outcome of Board Meeting held on March 19, 2024
21.03.2024 Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
21.03.2024 Audio Recording of Q3 Earnings call held today i.e March 21, 2024
20.03.2024 Newspaper Publication of Q3 Financial Results and Notice of Record Date
19.03.2024 Revised Notice of Record Date
19.03.2024 Submission of Investors Presentation Q3FY24
19.03.2024 Intimation in terms of Regulation 30(5) of the SEBI (Listing Obligations and DisclosureRequirements) Regulations, 2015.
19.03.2024 Press Release on Q3 FY 2024 Financial Results
19.03.2024 Declaration of Second Interim Dividend and Notice of Record Date
19.03.2024 Submission of Un-AuditedFinancial Results for theQuarter and Nine Months ended December 31, 2023
19.03.2024 Outcome of Board Meeting held on March 19, 2024.
18.03.2024 Intimation of Earnings Call to discuss the financial performance of the Company for the 3rd quarter ended December 31, 2023
17.03.2024 Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
12.03.2024 Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI(LODR), Regulations 2015
11.03.2024 Intimation of Board Meeting pursuant to Regulations 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on March 19, 2024.
02.03.2024 Closure of Trading Window

Secretarial Compliance Report

Date Documents Download
31.03.2024 Secretarial Compliance Report for the year ended March 31, 2024

Annual Return

Documents Download
MGT-7 (Annual Return)- 2022-23
MGT-7 (Annual Return)- 2021-22
MGT-7 (Annual Return)- 2020-21

Code of conduct

Documents Download
Code of conduct

Reports on Corporate Governance

Financial Year Q1 Q2 Q3 Q4
2023-24 NA NA NA

Credit Rating

The long term and short term credit facilities are rated by CRISIL and the present rating of the Company is CRISIL A-/Stable (Reaffirmed)-Long Term Rating and CRISIL A2+ (Reaffirmed)-Short Term Ratingon November 28, 2023

Committees of the Board

Audit Committee
Sl No. Name Position Category
1 Mr. Deepak Pramanik Chairman Non-Executive – Independent Director
2 Mr. Kashi Prasad Khandelwal Member Non-Executive – Independent Director
3 Mr. Amrendra Prasad Verma Member Non-Executive – Independent Director
Stakeholders Relationship Committee
Sl No. Name Position Category
1 Mr. Hari Modi Chairman Non-Executive Independent Director
2 Dr. Tapti Sen Member Non-Executive Independent Director
3 Mr. Anurag Tantia Member Whole-time Director
Nomination and Remuneration Committee
Sl No. Name Position Category
1 Mr. Kashi Prasad Khandelwal Chairman Non-Executive – Independent Director
2 Dr. Tapti Sen Member Non-Executive – Independent Director
3 Mr. Hari Modi Member Non-Executive – Independent Director
Corporate Social Responsibility Committee
Sl No. Name Position Category
1 Mr. Dwarika Prasad Tantia Chairman Chairman & Whole-time Director
2 Dr. Aruna Tantia Member Non-Executive – Non-Independent Director
3 Dr. Tapti Sen Member Non-Executive – Independent Director
Risk Management Committee
Sl No. Name Position Category
1 Mr. Amrendra Prasad Verma Chairman Non-Executive – Independent Director
2 Mr. Kashi Prasad Khandelwal Member Non-Executive – Independent Director
3 Mr. Anurag Tantia Member Whole-time Director
4 Mrs Kriti Tantia Permanent Invitee CFO

Board of Directors

ils-leader

Mr. Dwarika Prasad Tantia

Designation: Chairman & Whole-time Director

Dr. Om Tantia

Dr. Om Tantia

Designation: Managing Director

ils-leader

Dr. Aruna Tantia

Designation: Non-Executive Director

ils-leader

Dr. Ghanshyam Goyal

Designation: Non-Executive Director

ils-leader

Mr. Anurag Tantia

Designation: Whole-time Director

ils-leader

Mr. Kashi Prasad Khandelwal

Designation: Independent Director

ils-leader

Mr. Amrendra Prasad Verma

Designation: Independent Director

ils-leader

Mr. Deepak Pramanik

Designation: Independent Director

ils-leader

Dr. Tapti Sen

Designation: Independent Director

ils-leader

Mr. Hari Modi

Designation: Independent Director

Stock Information

Listing Information

"The equity shares of GPT Healthcare Limted is listed on National Stock
Exchange of India Limited and BSE Limited. w.e.f. February 29, 2024"

National Stock Exchange (NSE)


Exchange Plaza, C-1, Block G Bandra Kurla Complex Bandra (E)
Mumbai 400 051

www.nseindia.com

The Bombay Stock Exchange Limited (BSE)


Phiroze Jeejeebhoy Towers Dalal Street
Mumbai 400 001

www.bseindia.com

Stock Code
BSE Scrip Code 544131
NSE Scrip Code GPTHEALTH

Changes in the company name

Our Company was originally incorporated as "Jibansatya Printing House Private Limited", a private limited company under the Companies Act, 1956 on August 17, 1989 at Kolkata, West Bengal. The name of our Company was subsequently changed to "GPT Healthcare Private Limited" on March 31, 2005. Thereafter, our Company was converted to a public limited company and our name was changed to "GPT Healthcare Limited on September 15, 2021.

Financials

Quarterly Results

2023 - 2024 Q 1 Q 2 Q 3 Q 4
Standalone NA NA

Annual Reports

Downloads

Form Download-Form(pdf) Purpose
Form ISR-1
Request Form for Registering
Request for Registering PAN, KYC details OR Changes/updations there of (only for securities held in physical)
Form ISR-2
Bank Verification for Sign
Confirmation of Signature of securities holder by Banker
Form ISR-3
ISR-3 Opt Out
Declaration for Opting-out of Nomination by holders of physical securities in Listed Companies
Form SH-13
SH-13 Registration of Nominationn
Nomination Form
Form SH-14
Cancellation OR Variation of Nomination
Cancellation OR Variation of Nomination

Contact

Investor Relations/
Grievance Redressal/
Nodal Officer for IEPF

Company Secretary & Compliance Officer


GPT Healthcare Limited
Mr. Ankur Sharma
GPT Centre, JC-25, Sector-III
Salt Lake, Kolkata - 700 106
+91 33 4050 7000
ghl.cosec@gptgroup.co.in

Registrar & Share Transfer Agent


MUMBAI
Link Intime India Pvt. Ltd.
C-101, 247 Park,
LBS MARG, Vikhroli (West)
Mumbai - 400083
+91 22 49186200
gpthealthcare.ipo@linkintime.co.in

KOLKATA
Link Intime India Pvt. Ltd.
Room Nos.: 502 & 503, 5th floor, Vaishno Chamber 6 Brabourne Road,
Kolkata - 700 001
+033- 4004 9728 / 033- 4073 1698
kolkata@linkintime.co.in